scispace - formally typeset
R

Rui Tian

Researcher at National Institutes of Health

Publications -  60
Citations -  5722

Rui Tian is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Drug delivery & Cancer immunotherapy. The author has an hindex of 29, co-authored 56 publications receiving 3085 citations. Previous affiliations of Rui Tian include Jilin University & Xiamen University.

Papers
More filters
Journal ArticleDOI

Synthesis of Copper Peroxide Nanodots for H2O2 Self-Supplying Chemodynamic Therapy.

TL;DR: The fabrication of copper peroxide (CP) nanodot is reported, which is the first example of a Fenton-type metal peroxide nanomaterial, and its use as an activatable agent for enhanced CDT by self-supplying H2O2.
Journal ArticleDOI

Near-Infrared-II Molecular Dyes for Cancer Imaging and Surgery.

TL;DR: This review focuses on summarizing organic dyes emitting at a biological transparency window termed the near‐infrared‐II (NIR‐II) window, where minimal light interaction with the surrounding tissues allows photons to travel nearly unperturbed throughout the body.
Journal ArticleDOI

Biomineralization-Inspired Synthesis of Copper Sulfide-Ferritin Nanocages as Cancer Theranostics.

TL;DR: The results demonstrate that the bioinspired multifunctional CuS-Fn NCs have potential as clinically translatable cancer theranostics and could provide a noninvasive, highly sensitive, and quantitative in vivo guiding method for cancer photothermal therapies in experimental and clinical settings.
Journal ArticleDOI

Activatable Singlet Oxygen Generation from Lipid Hydroperoxide Nanoparticles for Cancer Therapy

TL;DR: This study demonstrates the effectiveness of modulating biochemical reactions as a ROS source to exert cancer death through tumor-specific 1 O2 generation and subsequent ROS mediated mechanism.
Journal ArticleDOI

Toxic Reactive Oxygen Species Enhanced Synergistic Combination Therapy by Self-Assembled Metal-Phenolic Network Nanoparticles.

TL;DR: A novel ROS promoted synergistic nanomedicine platform for cancer therapy is established via a biocompatible metal‐polyphenol networks self‐assembly process by encapsulating doxorubicin and platinum prodrugs in nanoparticles.